
    
      The immunogenicity of the PCV13 (13 valent pneumococcal conjugated vaccine) vaccine as
      compared to the PPV23 (23 valent pneumococcal polysaccharide vaccine) vaccine in patients
      treated with chronic hemodialysis that are pre-immunized with the PPV23 vaccine or are PPV23
      vaccine na√Øve will be measured by ELISA and OPA (opsonophagocytic assay) titers after 4 and
      52 weeks.
    
  